Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | SPRY2 |
| Upstream (Parents) |
|---|
| (<<) AKAP12 → SPRY2 |
| (<<) CAV1 → SPRY2 |
| (<<) CREB1 → SPRY2 |
| (<<) CRYAB → SPRY2 |
| (<<) G0S2 → SPRY2 |
| (<<) IGFBP7 → SPRY2 |
| (<<) ITGAV → SPRY2 |
| (<<) KCTD12 → SPRY2 |
| (<<) KLF10 → SPRY2 |
| (<<) PRNP → SPRY2 |
| (<<) PTGER4 → SPRY2 |
| (<<) RECK → SPRY2 |
| (<<) RNF111 → SPRY2 |
| Downstream (Children) |
|---|
| SPRY2 → ADCY7 (>>) |
| SPRY2 → AREG (>>) |
| SPRY2 → CHI3L1 (>>) |
| SPRY2 → CHST10 (>>) |
| SPRY2 → CHST12 (>>) |
| SPRY2 → CLDN5 (>>) |
| SPRY2 → CSTA (>>) |
| SPRY2 → CXCL1 (>>) |
| SPRY2 → CXCL2 (>>) |
| SPRY2 → EFEMP1 (>>) |
| SPRY2 → EGFR (>>) |
| SPRY2 → ETS2 (>>) |
| SPRY2 → GNAI1 (>>) |
| SPRY2 → HOPX (>>) |
| SPRY2 → HS3ST1 (>>) |
| SPRY2 → IGFBP6 (>>) |
| SPRY2 → IL18 (>>) |
| SPRY2 → ITPR1 (>>) |
| SPRY2 → KLF2 (>>) |
| SPRY2 → MEF2A (>>) |
| SPRY2 → MSN (>>) |
| SPRY2 → PLA2G4A (>>) |
| SPRY2 → PPAP2A (>>) |
| SPRY2 → PTPLA (>>) |
| SPRY2 → RAC2 (>>) |
| SPRY2 → RBP1 (>>) |
| SPRY2 → ROBO3 (>>) |
| SPRY2 → SHFM1 (>>) |
| SPRY2 → SOD3 (>>) |
| SPRY2 → TPSG1 (>>) |
